Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/02/2005EP1591448A2 Novel nucleic acids and polypeptides
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591127A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE
11/02/2005EP1590666A1 Compositions and methods for enhancing apoptosis
11/02/2005EP1590663A2 Immunocompromised rodents as dual color tumor models
11/02/2005EP1590661A2 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders
11/02/2005EP1590480A2 Novel proteins and nucleic acids encoding same
11/02/2005EP1590476A2 Protein fragment complementation assays for high-throughput and high-content screening
11/02/2005EP1590462A2 Mucin-like polypeptides
11/02/2005EP1590459A2 Methods for increasing neisseria protein expression and compositions thereof
11/02/2005EP1590450A2 Recombinant virus production for the manufacturing of vaccines
11/02/2005EP1590447A2 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
11/02/2005EP1590443A2 Surface expression of biologically active proteins in bacteria
11/02/2005EP1590441A2 Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 15
11/02/2005EP1590438A2 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
11/02/2005EP1590437A2 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
11/02/2005EP1590436A2 Rat receptor tyrosine kinase, kdr
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590432A2 Dna compositon and uses thereof
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590367A2 Control of plant growth and developmental processes
11/02/2005EP1590365A2 Mycobacterial diagnostics
11/02/2005EP1590363A2 Bh3 peptides and method of use thereof
11/02/2005EP1590061A1 Method for purification of alpha-1-antitrypsin
11/02/2005EP1589994A2 Composition and method for preventing or treating a virus infection
11/02/2005EP1589988A2 Modulation of activity of neurotrophins
11/02/2005EP1589987A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
11/02/2005EP1589986A2 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
11/02/2005EP1589981A2 Interferon antagonists useful for the treatment of interferon related diseases
11/02/2005EP1589980A2 Methods of diagnosis and treatment of interstitial lung disease
11/02/2005EP1589813A2 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
11/02/2005EP1589811A2 Non-touch zona pellucida microdrilling of a single-cell embryo with a 1.48 um diode laser beam for introduction of retrovirus
11/02/2005EP1444261B1 Immunogenic alk (anaplastic lymphoma kinase) peptides
11/02/2005EP1430071A4 Secreted and cell surface genes expressed in benign and malignant colorectal tumors
11/02/2005EP1421214A4 Amplified oncogenes and their involvement in cancer
11/02/2005EP1381272A4 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1268524B1 Binding peptides for carcinoembryonic antigen (cea)
11/02/2005EP1200563B1 Attenuated influenza virus useful as vaccine
11/02/2005EP1196128B1 Preserving a hemoglobin blood substitute with a transparent overwrap
11/02/2005EP1187845B1 Tumor suppressor molecules and methods of use
11/02/2005EP1183355B1 T-bet compositions and methods of use thereof
11/02/2005EP1168923B1 Dna vaccination for treatment of autoimmune disease
11/02/2005EP1141237B1 Pth receptor and screening assay utilizing the same
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1005488B1 Receptor that binds trail
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005EP0973540B1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
11/02/2005EP0970119B1 Synaptic activation protein compositions and method
11/02/2005EP0956357B1 Invertase inhibitor
11/02/2005EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses
11/02/2005EP0793675B1 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission
11/02/2005EP0601135B1 Osteogenic proteins in the treatment of metabolic bone diseases
11/02/2005CN1692126A P53 binding polypeptide
11/02/2005CN1692125A Treatment of infections and other disorders
11/02/2005CN1692124A P53 binding T cell receptor molecules and uses thereof
11/02/2005CN1692121A A full-length polynucleotide sequence coding chicken type II collagen and the use of it
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2005CN1690078A Horny cell growth factor mutant with high bioactivity and its preparation process and use thereof
11/02/2005CN1690077A Compositions for the therapy and diagnosis of prostate cancer and its uses
11/02/2005CN1690076A Use of ocean green algae in extraction of cyclic peptide components with anti-tumor activity
11/02/2005CN1690075A Process and preparing leptospira InvA and use thereof
11/02/2005CN1690074A Polypetide from haliotidae (PFH), its preparation and use in bio-medicine
11/02/2005CN1225648C Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
11/02/2005CN1225555C Human TOLL-like receptor proteins, related reagents and methods
11/02/2005CN1225477C Lung cancer early stage serum specific protein and its application
11/02/2005CN1225476C Human cervical cancer 1 protooncogene and protein encoded therein
11/02/2005CN1225475C Candida albicans molecular companion gene and its use
11/02/2005CN1225473C Method of preparing cyclic vasoactive peptides
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/01/2005US6961664 Methods of populating data structures for use in evolutionary simulations
11/01/2005US6960709 Method for altering the nutritional content of plant seed
11/01/2005US6960705 Nuclelotide sequence coding preferential protein; for use in generation of disease and stress resistant plants; biological pest control
11/01/2005US6960659 immunoreactive antigenic epitopes from several genotypes of hepatitis C virus; vaccines
11/01/2005US6960658 Maspin transcriptional regulatory sequences and uses thereof
11/01/2005US6960656 RNA encodes a novel sub-class of immunoglobulin superfamily with highest homologies to neural cell adhesion molecules Down Syndrome-Cell Adhesion Molecule (DS-CAM)
11/01/2005US6960652 Used to produce immunotoxins (ITs) and cytokines with a reduced ability to promote vascular leak syndrome (VLS)
11/01/2005US6960651 TANGO 332 polypeptides
11/01/2005US6960650 Nucleotide sequences coding proteins for use in the treatment of tumors
11/01/2005US6960649 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of alzheimer's and heart diseases
11/01/2005US6960647 Detection of transcriptional modulators; obtain transcription factor, incbate with modulator, monitor ajustment in geen expression activities
11/01/2005US6960646 Cyclic peptides as potent and selective melanocortin-4 receptors agonists
11/01/2005US6960570 Compositions and methods for the therapy and diagnosis of lung cancer
11/01/2005US6960569 Hepatitis C virus non-structural NS3/4A fusion gene
11/01/2005US6960562 Administering to said mammal a megakaryocyte stimulating factor (MSF) or alternatively spliced variant to reduce a symptom of osteoarthritis in a mammal
11/01/2005US6960559 Neurite growth regulatory factors
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
11/01/2005US6960465 Increased cell resistance to toxic organic substances
11/01/2005US6960463 Separation of fibrinogen from plasma proteases
11/01/2005US6960452 Peptide chimera comprising polysaccharide-binding domain and second domain comprising factor XIIIa substrate and/or peptide, useful for enhancing healing of tissues of vasculature, skin, nervous systems, and the liver
11/01/2005US6960447 Isolation of membrane bound ligand-specific complexes
11/01/2005US6960446 Nucleotide sequences coding enzymatic polypeptide; for use in bone marrow therapy
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960443 Anticancer, antitumor agents; monoclonal antibodies; genetic engineered protein
11/01/2005US6960442 Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
11/01/2005US6960440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/01/2005US6960438 Method for the affinity isolation of newly synthesized RNA